Effects of Curcumin along with Radiotherapy of Oral Cancer
Phase 4
- Conditions
- Health Condition 1: null- â?¢Post surgical resection cases of Carcinoma Buccal Mucosa, Gingiva/Alveolus, Retromandibular Trigone, Oral Tongue, Lips, Floor of Mouth, Hard Palateâ?¢Histology proven Squamous cell carcinoma
- Registration Number
- CTRI/2015/12/006413
- Lead Sponsor
- Dr Tej Prakash Soni
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
•Post surgical resection cases of Carcinoma Buccal Mucosa, Gingiva/Alveolus, Retromandibular Trigone, Oral Tongue, Lips, Floor of Mouth, Hard Palate
•Histology proven Squamous cell carcinoma
•Age >18 years to <70 years
•WHO Performance Status 0-1
•No prior history of Radiotherapy to head neck region
Exclusion Criteria
•Primary Site of Oropharynx, Nasopharynx, Larynx
•History of previous Radiotherapy to head neck region
•Histopathology other than squamous cell carcinoma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine whether supplementation of curcumin reduces the severity of Oral Mucositis in patients receiving radiotherapy for Oral CancersTimepoint: One year from enrollment of the first patient
- Secondary Outcome Measures
Name Time Method TO DETERMINE THE QUALITY OF LIFETimepoint: 6 WEEKS PER PATIENT